BigBear.ai (NYSE:BBAI), a specialized defense and security technology company providing mission-read

Gainers NextCure (NASDAQ:NXTC) stock increased by 201.4% to $6.57 during Tuesday's regular sess

Gainers Catheter Precision (AMEX:VTAK) shares moved upwards by 95.7% to $1.4 during Wednesday's

Gainers Innovative Eyewear (NASDAQ:LUCY) stock moved upwards by 95.4% to $1.49 during Monday's

BioXcel Therapeutics (BTAI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism

BioXcel Therapeutics, Inc. (NASDAQ:BTAI), a biopharmaceutical company built on artificial intelligen

NEW HAVEN, Conn., May 28, 2026 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biop

BioXcel Therapeutics, Inc. (BTAI) came out with a quarterly loss of $0.54 per share versus the Zacks

FDA accepted sNDA for IGALMI® use in at-home (outpatient) setting; set Nov. 14, 2026, as PDUFA date 

BioXcel Therapeutics (BTAI) possesses the right combination of the two key ingredients for a likely

BioXcel Therapeutics (NASDAQ: BTAI) outlined its commercial strategy and launch preparations for IGA

BioXcel Therapeutics, Inc. (BTAI) Discusses Commercial Launch Strategy and Market Opportunity for IG

Live event to be held on Thursday, April 23, at 2:00 p.m. ET  Company focused on advancing launch st

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or ob

DoW-funded Phase 2a trial led by University of North Carolina at Chapel Hill (UNC) Institute for Tra

PDUFA target action date of November 14, 2026 Potential first FDA-approved treatment option for the

sNDA submitted seeking approval of IGALMI® in the at-home (outpatient) setting for the treatment of

HARTFORD, Conn., March 23, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that the United

NEW HAVEN, Conn., March 11, 2026 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nas

NEW HAVEN, Conn., March 10, 2026 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nas

BioXcel Therapeutics Inc. (NASDAQ: BTAI) shares are down on Friday.

BXCL501 demonstrated clinical benefits and favorable tolerability profile for treatment of opioid wi

BioXcel Therapeutics, Inc. (BTAI) Discusses Phase III Results and Advances in Treating Acute Agitati

Discussion will focus on the high unmet need and the lack of FDA-approved treatment options associat

BioXcel Therapeutics, Inc. (NASDAQ: BTAI - Get Free Report) was the recipient of a large increase in

Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for tra

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for it

  On Tuesday, 647 companies set new 52-week lows.

  On Monday, 369 companies set new 52-week lows.

  During Thursday's session, 406 companies made new 52-week lows.

  During the session on Thursday, 461 stocks hit new 52-week lows.

Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report q

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is expected to report earnings for

Gainers

Upgrades

  On Wednesday, 807 companies reached new 52-week lows.

  Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its fir

  Companies Reporting Before The Bell • Celsius Holdings (NASDAQ:CELH) is estimated to report quar

Stocks Which Set New 52-Week Low Last Trading Session, Fri., Dec. 14, 2018

Stocks Which Set New 52-Week Low Yesterday, October 23rd